184 related articles for article (PubMed ID: 19254847)
1. Synthesis and vasodilator effects of rutaecarpine analogues which might be involved transient receptor potential vanilloid subfamily, member 1 (TRPV1).
Chen Z; Hu G; Li D; Chen J; Li Y; Zhou H; Xie Y
Bioorg Med Chem; 2009 Mar; 17(6):2351-9. PubMed ID: 19254847
[TBL] [Abstract][Full Text] [Related]
2. The depressor and vasodilator effects of rutaecarpine are mediated by calcitonin gene-related peptide.
Hu CP; Xiao L; Deng HW; Li YJ
Planta Med; 2003 Feb; 69(2):125-9. PubMed ID: 12624816
[TBL] [Abstract][Full Text] [Related]
3. Solid dispersion of rutaecarpine improved its antihypertensive effect in spontaneously hypertensive rats.
Ding JS; Gao R; Li D; Peng J; Ran LL; Li YJ
Biopharm Drug Dispos; 2008 Dec; 29(9):495-500. PubMed ID: 19016276
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats.
Li D; Peng J; Xin HY; Luo D; Zhang YS; Zhou Z; Jiang DJ; Deng HW; Li YJ
Peptides; 2008 Oct; 29(10):1781-8. PubMed ID: 18625276
[TBL] [Abstract][Full Text] [Related]
5. Dual-targeting Rutaecarpine-NO donor hybrids as novel anti-hypertensive agents by promoting release of CGRP.
Ma J; Chen L; Fan J; Cao W; Zeng G; Wang Y; Li Y; Zhou Y; Deng X
Eur J Med Chem; 2019 Apr; 168():146-153. PubMed ID: 30818175
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin gene-related Peptide-mediated depressor effect and inhibiting vascular hypertrophy of rutaecarpine in renovascular hypertensive rats.
Qin XP; Zeng SY; Li D; Chen QQ; Luo D; Zhang Z; Hu GY; Deng HW; Li YJ
J Cardiovasc Pharmacol; 2007 Dec; 50(6):654-9. PubMed ID: 18091582
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of novel rutaecarpine derivatives and related alkaloids derivatives as selective acetylcholinesterase inhibitors.
Wang B; Mai YC; Li Y; Hou JQ; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2010 Apr; 45(4):1415-23. PubMed ID: 20079560
[TBL] [Abstract][Full Text] [Related]
8. Involvement of TRPV1 in the expression and release of calcitonin gene-related peptide induced by rutaecarpine.
Yang Y; Chen Q; Jia S; He L; Wang A; Li D; Li Y; Li X
Mol Med Rep; 2018 Apr; 17(4):5168-5174. PubMed ID: 29393417
[TBL] [Abstract][Full Text] [Related]
9. Rutaecarpine: A promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu).
Tian KM; Li JJ; Xu SW
Pharmacol Res; 2019 Mar; 141():541-550. PubMed ID: 30616017
[TBL] [Abstract][Full Text] [Related]
10. The protective effects of rutaecarpine on gastric mucosa injury in rats.
Wang L; Hu CP; Deng PY; Shen SS; Zhu HQ; Ding JS; Tan GS; Li YJ
Planta Med; 2005 May; 71(5):416-9. PubMed ID: 15931578
[TBL] [Abstract][Full Text] [Related]
11. Rutaecarpine prevented dysfunction of endothelial gap junction induced by Ox-LDL via activation of TRPV1.
Peng WJ; Liu Y; Yu YR; Fu YQ; Zhao Y; Kuang HB; Huang QR; He M; Luo D
Eur J Pharmacol; 2015 Jun; 756():8-14. PubMed ID: 25794845
[TBL] [Abstract][Full Text] [Related]
12. Reduction of asymmetric dimethylarginine in the protective effects of rutaecarpine on gastric mucosal injury.
Liu YZ; Zhou Y; Li D; Wang L; Hu GY; Peng J; Li YJ
Can J Physiol Pharmacol; 2008 Oct; 86(10):675-81. PubMed ID: 18841172
[TBL] [Abstract][Full Text] [Related]
13. Partial Activation and Inhibition of TRPV1 Channels by Evodiamine and Rutaecarpine, Two Major Components of the Fruits of Evodia rutaecarpa.
Wang S; Yamamoto S; Kogure Y; Zhang W; Noguchi K; Dai Y
J Nat Prod; 2016 May; 79(5):1225-30. PubMed ID: 27159637
[TBL] [Abstract][Full Text] [Related]
14. Effects of Evodia rutaecarpa and rutaecarpine on the pharmacokinetics of caffeine in rats.
Tsai TH; Chang CH; Lin LC
Planta Med; 2005 Jul; 71(7):640-5. PubMed ID: 16041650
[TBL] [Abstract][Full Text] [Related]
15. Effects of rutaecarpine on the metabolism and urinary excretion of caffeine in rats.
Noh K; Seo YM; Lee SK; Bista SR; Kang MJ; Jahng Y; Kim E; Kang W; Jeong TC
Arch Pharm Res; 2011 Jan; 34(1):119-25. PubMed ID: 21468923
[TBL] [Abstract][Full Text] [Related]
16. Reversal of isoprenaline-induced cardiac remodeling by rutaecarpine via stimulation of calcitonin gene-related peptide production.
Li JZ; Peng J; Xiao L; Zhang YS; Liao MC; Li XH; Hu CP; Deng HW; Li YJ
Can J Physiol Pharmacol; 2010 Oct; 88(10):949-59. PubMed ID: 20962894
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of CYP1A1 by rutaecarpine is dependent on aryl hydrocarbon receptor and calcium.
Han EH; Kim HG; Im JH; Jeong TC; Jeong HG
Toxicology; 2009 Dec; 266(1-3):38-47. PubMed ID: 19853001
[TBL] [Abstract][Full Text] [Related]
18. Progress in Studies on Rutaecarpine. II.--Synthesis and Structure-Biological Activity Relationships.
Son JK; Chang HW; Jahng Y
Molecules; 2015 Jun; 20(6):10800-21. PubMed ID: 26111170
[TBL] [Abstract][Full Text] [Related]
19. Rutaecarpine prevented ox-LDL-induced VSMCs dysfunction through inhibiting overexpression of connexin 43.
Wang M; Wu Y; Yu Y; Fu Y; Yan H; Wang X; Li T; Peng W; Luo D
Eur J Pharmacol; 2019 Jun; 853():84-92. PubMed ID: 30880182
[TBL] [Abstract][Full Text] [Related]
20. Ethanol causes neurogenic vasodilation by TRPV1 activation and CGRP release in the trigeminovascular system of the guinea pig.
Nicoletti P; Trevisani M; Manconi M; Gatti R; De Siena G; Zagli G; Benemei S; Capone JA; Geppetti P; Pini LA
Cephalalgia; 2008 Jan; 28(1):9-17. PubMed ID: 17888011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]